Moderna, Inc. (MRNA)
NASDAQ: MRNA · Real-Time Price · USD
149.66
-9.17 (-5.77%)
At close: Aug 26, 2026, 4:00 PM EDT
147.66
-2.00 (-1.34%)
After-hours: Aug 26, 2026, 7:59 PM EDT
Moderna Market Cap
Moderna has a market cap or net worth of $59.75 billion as of August 26, 2026. Its market cap has increased by 505.79% in one year.
Market Cap
59.75B
Enterprise Value
54.13B
1-Year Change
505.79%
Ranking
Category
Stock Price
$149.66
ChartMarket Cap Chart
Since December 7, 2018, Moderna's market cap has increased from $6.12B to $59.75B, an increase of 876.55%. That is a compound annual growth rate of 34.32%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 26, 2026 | 59.75B | 418.54% |
| Dec 31, 2025 | 11.52B | -27.99% |
| Dec 31, 2024 | 16.00B | -57.80% |
| Dec 29, 2023 | 37.92B | -45.05% |
| Dec 30, 2022 | 69.01B | -32.99% |
| Dec 31, 2021 | 102.98B | 149.10% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 7, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Vertex Pharmaceuticals | 139.71B |
| Regeneron Pharmaceuticals | 83.13B |
| argenx SE | 63.06B |
| Revolution Medicines | 46.01B |
| BeOne Medicines AG | 42.70B |
| Royalty Pharma | 35.49B |
| Alnylam Pharmaceuticals | 31.83B |
| BioNTech SE | 29.16B |